Sale!

Pulmonary Panel NGS Genetic Test Cost

Original price was: 6,000 د.إ.Current price is: 4,400 د.إ.

-27%

The Pulmonary Panel NGS (Next-Generation Sequencing) Genetic Test offered by DNA Labs UAE is a cutting-edge diagnostic tool designed to identify genetic mutations associated with various pulmonary conditions. By analyzing a comprehensive panel of genes known to be linked to lung diseases, this test provides valuable insights that can guide personalized treatment plans and management strategies for patients. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise involved in conducting the analysis. With the potential to uncover genetic predispositions and inform clinical decisions, the Pulmonary Panel NGS Genetic Test represents a significant advancement in the field of pulmonary medicine, offering hope for improved outcomes for individuals with inherited lung disorders.

Description

Pulmonary Panel NGS Genetic Test

Test Name: Pulmonary panel NGS Genetic DNA Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test type: Cardiovascular Pneumology Disorders

Doctor: Cardiologist

Test Department: Genetics

Pre Test Information:

Clinical History of Patient who is going for Pulmonary panel NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ABCA3, ABCC8, ACVRL1, AP3B1, ASCL1, BLOC1S3, BLOC1S6, BMPR1B, BMPR2, CAV1, CCDC39, CCDC40, CFTR, CHAT, CHRNA1, CHRNB1, CHRND, CHRNE, COLQ, CSF2RA, CSF2RB, DKC1, DNAAF1, DNAAF2, DNAH11, DNAH5, DNAH9, DNAI1, DNAI2, DNAL1, DOCK8, DTNBP1, ECE1, EDN3, EFEMP2, EIF2AK4, ELN, ENG, FBLN5, FBN1, FLCN, FOXF1, GDF2, GDNF, GLRA1, HPS1, HPS3, HPS4, HPS5, HPS6, ITGA3, KCNA5, KCNK3, MECP2, NF1, NFU1, NKX2-1, NME8, NOP10, NOTCH3, PARN, PHOX2A, PHOX2B, POLD1, RAPSN, RASA1, RET, RSPH1, RSPH4A, RSPH9, RTEL1, SARS2, SCN4A, SCNN1A, SCNN1B, SCNN1G, SERPINA1, SFTPA2, SFTPB, SFTPC, SLC6A5, SLC7A7, SMAD4, SMAD9, SMPD1, STAT3, STRA6, TERT, TINF2, TSC1, TSC2, ZEB2

Test Details:

The Pulmonary Panel NGS Genetic DNA Test is a genetic test that uses next-generation sequencing (NGS) technology to analyze a patient’s DNA for mutations that may be associated with pulmonary diseases. This test can identify mutations in genes that are known to be associated with a variety of pulmonary conditions, including cystic fibrosis, alpha-1 antitrypsin deficiency, and pulmonary hypertension.

NGS technology allows for the analysis of multiple genes at once, making it a more efficient and comprehensive approach to genetic testing. The results of the Pulmonary Panel NGS Genetic DNA Test can help physicians diagnose and manage pulmonary diseases, as well as provide information about potential risks for family members.

This test is typically ordered for patients with symptoms of pulmonary disease or a family history of pulmonary conditions. It may also be recommended for individuals who are planning to start a family and want to assess their risk for passing on genetic mutations to their children.

It is important to note that genetic testing is not a replacement for clinical evaluation and diagnosis by a healthcare professional. The results of genetic testing should be interpreted in the context of a patient’s medical history and other clinical factors.

Test Name	Pulmonary panel NGS Genetic DNA Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Cardiovascular Pneumology Disorders
Doctor	Cardiologist
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for Pulmonary panel NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ABCA3, ABCC8, ACVRL1, AP3B1, ASCL1, BLOC1S3, BLOC1S6, BMPR1B, BMPR2, CAV1, CCDC39, CCDC40, CFTR, CHAT, CHRNA1, CHRNB1, CHRND, CHRNE, COLQ, CSF2RA, CSF2RB, DKC1, DNAAF1, DNAAF2, DNAH11, DNAH5, DNAH9, DNAI1, DNAI2, DNAL1, DOCK8, DTNBP1, ECE1, EDN3, EFEMP2, EIF2AK4, ELN, ENG, FBLN5, FBN1, FLCN, FOXF1, GDF2, GDNF, GLRA1, HPS1, HPS3, HPS4, HPS5, HPS6, ITGA3, KCNA5, KCNK3, MECP2, NF1, NFU1, NKX2-1, NME8, NOP10, NOTCH3, PARN, PHOX2A, PHOX2B, POLD1, RAPSN, RASA1, RET, RSPH1, RSPH4A, RSPH9, RTEL1, SARS2, SCN4A, SCNN1A, SCNN1B, SCNN1G, SERPINA1, SFTPA2, SFTPB, SFTPC, SLC6A5, SLC7A7, SMAD4, SMAD9, SMPD1, STAT3, STRA6, TERT, TINF2, TSC1, TSC2, ZEB2
Test Details	The Pulmonary Panel NGS Genetic DNA Test is a genetic test that uses next-generation sequencing (NGS) technology to analyze a patient’s DNA for mutations that may be associated with pulmonary diseases. This test can identify mutations in genes that are known to be associated with a variety of pulmonary conditions, including cystic fibrosis, alpha-1 antitrypsin deficiency, and pulmonary hypertension. NGS technology allows for the analysis of multiple genes at once, making it a more efficient and comprehensive approach to genetic testing. The results of the Pulmonary Panel NGS Genetic DNA Test can help physicians diagnose and manage pulmonary diseases, as well as provide information about potential risks for family members. This test is typically ordered for patients with symptoms of pulmonary disease or a family history of pulmonary conditions. It may also be recommended for individuals who are planning to start a family and want to assess their risk for passing on genetic mutations to their children. It is important to note that genetic testing is not a replacement for clinical evaluation and diagnosis by a healthcare professional. The results of genetic testing should be interpreted in the context of a patient’s medical history and other clinical factors.